analyst
RX
NASDAQ · RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Healthcare · Biotechnology
$3.66
Up+$0.05 (+1.39%)
Updated Oct 21, 2026, 4:27 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.83B
- P/E ratio
- -2.94
- Dividend yield
- 0.00%
- 52-week range
- $2.77 – $7.18
- Volume
- 20.8M
- Avg. volume
- 43.4M
Price performance · RXRX
RXRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
RXRX closed at $3.66 after 21 trading sessions, down 9.63% for the selected period.
- Last close
- $3.66
- Period change
- -9.63%
- Period low
- $3.47
- Period high
- $4.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $3.555 | $3.67 | $3.47 | $3.66 | 20.8M |
| Oct 19, 2026 | $3.53 | $3.69 | $3.48 | $3.61 | 30.01M |
| Oct 16, 2026 | $4.11 | $4.185 | $3.44 | $3.465 | 40.72M |
| Oct 15, 2026 | $3.65 | $4.41 | $3.53 | $4.16 | 62.87M |
| Oct 14, 2026 | $3.72 | $3.91 | $3.66 | $3.74 | 18.78M |
| Oct 13, 2026 | $4.01 | $4.05 | $3.82 | $3.835 | 19.76M |
| Oct 12, 2026 | $4.31 | $4.365 | $3.91 | $4.01 | 23.79M |
| Oct 9, 2026 | $4.015 | $4.43 | $3.89 | $4.36 | 35.5M |
| Oct 8, 2026 | $4.19 | $4.20 | $3.79 | $3.95 | 30.9M |
| Oct 7, 2026 | $4.505 | $4.60 | $4.23 | $4.27 | 40.73M |
| Oct 6, 2026 | $4.81 | $5.19 | $4.395 | $4.63 | 71.11M |
| Oct 5, 2026 | $4.16 | $4.935 | $4.0601 | $4.78 | 67.28M |
| Oct 2, 2026 | $4.18 | $4.27 | $4.01 | $4.12 | 18.84M |
| Oct 1, 2026 | $4.07 | $4.17 | $3.96 | $4.07 | 17.48M |
| Sep 30, 2026 | $4.09 | $4.29 | $3.98 | $4.13 | 32.79M |
| Sep 29, 2026 | $3.73 | $4.04 | $3.7225 | $4.03 | 21.56M |
| Sep 28, 2026 | $3.69 | $3.8399 | $3.665 | $3.70 | 13.06M |
| Sep 25, 2026 | $3.89 | $3.90 | $3.70 | $3.74 | 10.48M |
| Sep 24, 2026 | $3.65 | $3.90 | $3.61 | $3.89 | 19.34M |
| Sep 23, 2026 | $4.03 | $4.09 | $3.66 | $3.70 | 23.67M |
| Sep 22, 2026 | $4.00 | $4.16 | $3.90 | $4.05 | 40.46M |
Latest RXRX news
The latest Smart Investors Daily articles mentioning RXRX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

